A new device called Barostim is helping heart failure patients at Christ Hospital in Cincinnati live more normal lives without major surgery, as experienced by local grandfather Eric Townsend.For ...

CVRx, Inc. announced at the Technology and Heart Failure Therapeutics (THT) conference that new real-world evidence demonstrates significant reductions in hospital visits and length of stay after ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Chuck Moon, a congestive heart failure patient, experienced significant improvement in his quality of life after receiving a Barostim device implant. The Barostim device is a new technology that acts ...

WILMINGTON, NC (WWAY) — Novant Health New Hanover Regional Medical Center is offering the Barostim implant for heart failure patients. The first local recipient, Chuck Moon, says the results have been ...

MINNEAPOLIS, March 02, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for ...

TUCSON, Ariz. (KVOA) - Carondelet St. Mary's Hospital has successfully completed its first implantation of the Barostim™ Baroreflex Activation Therapy device, marking a significant advancement in the ...

The number of Americans living with congestive heart failure is on the rise; it’expected to affect more than eight million people by 2030. For many of those patients, medications stop working. Now a ...

CVRx Inc. CVRX announced a key reimbursement win after Humana issued a Medicare Advantage coverage policy for its Barostim therapy. The development marks an important step in expanding patient access ...

After years of work, Minnesota-based device firm CVRx has obtained approval from the Food and Drug Administration to sell its neurostimulation device for heart failure commercially in the United ...

FORT LAUDERDALE, Fla. (Ivanhoe Newswire) – The number of Americans living with congestive heart failure is on the rise. Heart failure is expected to affect more than 8 million people by 2030. For many ...

(NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular ...